Boehringer and Pfizer made significant performances in the outpatient prescription ranking

Published: 2015-02-17 16:28:00
Updated: 2015-02-17 10:54:04

It is found out that Products of BoehringerIngelheim Korea and Pfizer Korea has generated significant performances in the outpatient prescription market last year.

According to the analysis result of the top 30 outpatient prescription expense companies based on the UBIST data, the BoehringerInge...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.